ERBB2 and breast cancer: In contrast, among Hispanic Americans alone, HER2+ disease was instead associated with PGS313 with a higher OR than for all breast cancer risk (OR = 2.47, 95% CI = 1.39–4.41), although this analysis was limited, as there were only 18 patients within our cohort that were both Hispanic and HER2+.